Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study PROFILe3: Clinic Observations Profile of Relapse and Readmission in Emergency/Acute Settings: Epidemiologic Survey in Schizophrenic Patients

NCT00399334 is registered in ClinicalTrials.gov with Janssen-Cilag, S.A. as lead sponsor.

NCT NCT00399334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00399334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study PROFILe3: Clinic Observations Profile of Relapse and Readmission in Emergency/Acute Settings: Epidemiologic Survey in Schizophrenic Patients
Lead sponsor
Janssen-Cilag, S.A.
Phase
Observational
Overall status
Completed
Start date
June 30, 2005
Completion date
December 31, 2005
Enrollment
1,607 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia, schizophreniform disorder